XML 30 R44.htm IDEA: XBRL DOCUMENT v3.2.0.727
Subsequent Events - Additional Information (Detail)
 9 Months Ended 12 Months Ended
Sep. 30, 2015
USD ($)
Jun. 01, 2015
$ / shares
shares
May. 20, 2015
USD ($)
Apr. 16, 2015
USD ($)
shares
Mar. 31, 2015
$ / shares
shares
Jun. 30, 2015
USD ($)
Jun. 30, 2014
$ / shares
shares
Jun. 30, 2013
$ / shares
shares
Subsequent Event [Line Items]                
Common stock, shares purchased       4,761,787        
Common stock, authorized shares         300,000,000   300,000,000 300,000,000
Common Stock, par value | $ / shares         $ 0.0001   $ 0.0001 $ 0.0001
Preferred stock, authorized shares         50,000,000   50,000,000 50,000,000
Preferred Stock, par value | $ / shares         $ 0.0001   $ 0.0001 $ 0.0001
Reverse stock split, description         The reverse stock split was at a ratio of one new share for every 12.174 shares outstanding.      
Luoxis Diagnostics [Member]                
Subsequent Event [Line Items]                
Cancellation of indebtedness amount | $       $ 8,000,000        
Common stock, authorized shares             60,000,000 60,000,000
Common Stock, par value | $ / shares             $ 0.0001 $ 0.0001
Preferred stock, authorized shares             10,000,000 10,000,000
Preferred Stock, par value | $ / shares             $ 0.0001 $ 0.0001
Vyrix Pharmaceuticals [Member]                
Subsequent Event [Line Items]                
Cancellation of indebtedness amount | $       4,000,000        
Common stock, authorized shares             60,000,000 60,000,000
Common Stock, par value | $ / shares             $ 0.0001 $ 0.0001
Preferred stock, authorized shares             10,000,000 10,000,000
Preferred Stock, par value | $ / shares             $ 0.0001 $ 0.0001
Promissory Note [Member]                
Subsequent Event [Line Items]                
Debt instrument principal amount | $       $ 10,000,000        
Debt instrument, interest rate       0.40%        
Scenario, Forecast [Member] | ProstaScint Business [Member]                
Subsequent Event [Line Items]                
Business Acquisition, liabilities incurred | $ $ 226,523              
Subsequent Event [Member]                
Subsequent Event [Line Items]                
Common stock, authorized shares   50,000,000            
Common Stock, par value | $ / shares   $ 0.001            
Preferred stock, authorized shares   300,000,000            
Preferred Stock, par value | $ / shares   $ 0.001            
Common stock, shares authorized for issuance   10,000,000            
Reverse stock split ratio   0.0821            
Subsequent Event [Member] | ProstaScint Business [Member]                
Subsequent Event [Line Items]                
Business Acquisition, acquisition cost | $     $ 1,000,000          
Business Acquisition, liabilities incurred | $     $ 500,000          
Restructuring payment, contingent consideration     We also will pay 8% on net sales made after October 31, 2017, payable up to a maximum aggregate payment of $2.5 million.          
Business Acquisition, future contingent payments | $     $ 2,500,000          
Subsequent Event [Member] | Promissory Note [Member]                
Subsequent Event [Line Items]                
Promissory note, amount drawn | $           $ 5,000,000